报价延迟最少15分钟:2026/02/10 08:58 EST
盘前时段
|
||||
|
5.14 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.23/1.07
|
|
企业价值
2.75B
|
| 资产负债 |
|
每股账面净值
-0.57
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
489.68M
|
|
每股收益
0.20
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to treatments for various diseases. |
